Steris PLC has a consensus price target of $221.5, established from looking at the 37 latest analyst ratings. The last 3 analyst ratings were released from Stephens & Co., JMP Securities, and Keybanc on February 9, 2024, February 8, 2024, and February 6, 2024. With an average price target of $256 between Stephens & Co., JMP Securities, and Keybanc, there's an implied 13.87% upside for Steris PLC from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
02/09/2024 | STE | Buy Now | Steris | $224.82 | 11.2% | Stephens & Co. | Jacob Johnson | → $250 | Reiterates | Overweight → Overweight | Get Alert |
02/08/2024 | STE | Buy Now | Steris | $224.82 | 17.87% | JMP Securities | David Turkaly | → $265 | Reiterates | Market Outperform → Market Outperform | Get Alert |
02/06/2024 | STE | Buy Now | Steris | $224.82 | 12.53% | Keybanc | Brett Fishbin | → $253 | Initiates | → Overweight | Get Alert |
12/04/2023 | STE | Buy Now | Steris | $224.82 | -4.37% | Morgan Stanley | Patrick Wood | $225 → $215 | Maintains | Equal-Weight | Get Alert |
11/09/2023 | STE | Buy Now | Steris | $224.82 | 17.87% | JMP Securities | David Turkaly | → $265 | Reiterates | Market Outperform → Market Outperform | Get Alert |
10/27/2023 | STE | Buy Now | Steris | $224.82 | -4.37% | Piper Sandler | Jason Bednar | $220 → $215 | Maintains | Neutral | Get Alert |
10/26/2023 | STE | Buy Now | Steris | $224.82 | -4.37% | Piper Sandler | Jason Bednar | $220 → $215 | Maintains | Neutral | Get Alert |
09/25/2023 | STE | Buy Now | Steris | $224.82 | 11.2% | Stephens & Co. | Jacob Johnson | → $250 | Reiterates | Overweight → Overweight | Get Alert |
09/01/2023 | STE | Buy Now | Steris | $224.82 | 17.87% | JMP Securities | David Turkaly | $240 → $265 | Maintains | Market Outperform | Get Alert |
08/03/2023 | STE | Buy Now | Steris | $224.82 | 0.08% | Morgan Stanley | Patrick Wood | $206 → $225 | Maintains | Equal-Weight | Get Alert |
08/03/2023 | STE | Buy Now | Steris | $224.82 | 14.76% | Keybanc | Matthew Mishan | $254 → $258 | Maintains | Overweight | Get Alert |
08/02/2023 | STE | Buy Now | Steris | $224.82 | 6.75% | JMP Securities | David Turkaly | → $240 | Reiterates | Market Outperform → Market Outperform | Get Alert |
07/25/2023 | STE | Buy Now | Steris | $224.82 | 12.98% | Keybanc | Matthew Mishan | $235 → $254 | Maintains | Overweight | Get Alert |
07/17/2023 | STE | Buy Now | Steris | $224.82 | 11.2% | Stephens & Co. | Jacob Johnson | $240 → $250 | Maintains | Overweight | Get Alert |
05/30/2023 | STE | Buy Now | Steris | $224.82 | -8.37% | Morgan Stanley | Patrick Wood | → $206 | Initiates | → Equal-Weight | Get Alert |
05/12/2023 | STE | Buy Now | Steris | $224.82 | -11.04% | Piper Sandler | Jason Bednar | $197 → $200 | Maintains | Neutral | Get Alert |
05/12/2023 | STE | Buy Now | Steris | $224.82 | 4.53% | Keybanc | Matthew Mishan | $210 → $235 | Maintains | Overweight | Get Alert |
05/11/2023 | STE | Buy Now | Steris | $224.82 | 6.75% | JMP Securities | David Turkaly | → $240 | Reiterates | Market Outperform → Market Outperform | Get Alert |
04/14/2023 | STE | Buy Now | Steris | $224.82 | -12.37% | Piper Sandler | Jason Bednar | $215 → $197 | Downgrade | Overweight → Neutral | Get Alert |
The latest price target for Steris (NYSE: STE) was reported by Stephens & Co. on February 9, 2024. The analyst firm set a price target for $250.00 expecting STE to rise to within 12 months (a possible 11.20% upside). 19 analyst firms have reported ratings in the last year.
The latest analyst rating for Steris (NYSE: STE) was provided by Stephens & Co., and Steris reiterated their overweight rating.
The last upgrade for Steris PLC happened on May 26, 2021 when Needham raised their price target to $233. Needham previously had a hold for Steris PLC.
The last downgrade for Steris PLC happened on April 14, 2023 when Piper Sandler changed their price target from $215 to $197 for Steris PLC.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Steris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Steris was filed on February 9, 2024 so you should expect the next rating to be made available sometime around February 9, 2025.
While ratings are subjective and will change, the latest Steris (STE) rating was a reiterated with a price target of $0.00 to $250.00. The current price Steris (STE) is trading at is $224.82, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.